Arbudahara Tablet in management of oral squamous cell carcinoma

Clinical evaluation of Arbudahara Tablet as palliative care management along with radiotherapy in locally advanced oral squamous cell carcinoma - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/081882

Enrollment

Registered

2025-03-07

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients with sign and symptoms of oral Squamous cell carcinoma like mouth ulceration sore tongue Trismus jaw or facial swelling pain in oral cavity 2 patient diagnosed as squamous cell carcinoma after histopathological report & being submitted for radiotherapy or chemotherapy or both 3 controlled cases of hypertension diabetes mellitus 4 TNM criteria T1-T3 N1-N3 M0

Exclusion criteria

Exclusion criteria: 1 Metastasis T4M1 STAGE 2 Patients suffering from severe systemic disorders and diseases like HIV HbsAg STD TB etc 3 Uncontrolled DM Hypertension serious cardiac renal diseases hyperthyroidism

Design outcomes

Primary

Measure	Time frame
The study will improve quality of life of cancer patients Reduced the adverse effects of Radiotherapy and reducing disease symptom in oral cancer patientsTimepoint: 4week and 8 week	—

Secondary

Measure	Time frame
The study will improve quality of life of cancer patients.Reduced the adverse effects of radiotherapy and reducing symptoms in oral cancer patients.Timepoint: 60 days	—

Countries

India

Contacts

Public ContactDr vipul sangani

Government Akhandananda Ayurved College and Hospital

drvipulvsangani@gmail.com9998960732

Outcome results